Stay updated with breaking news from Emerging Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibe Therapeutics Inc. , a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, is pleased to provide a corporate... | April 11, 2023
VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCQB: VRRCF), the "Company", or “VR”, is pleased...
New recruit will oversee a strategy alongside the French group's head of emerging markets.
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 News provided by Share this article Share this article SAN DIEGO, March 11, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced program updates and financial results for the fourth quarter and full year ended December 31, 2020. "2020 was a transformative year for Poseida, as we completed ...